Alzheimer’s drug lowers levels of protein known to cause disease, suggests study

PA Wire

A new genetic therapy for Alzheimer’s disease is safe and successfully lowered levels of the harmful tau protein known to cause the disease, a new study suggests.

Researchers say the findings are a “significant” step forward in demonstrating it may be possible to target the protein to slow, or potentially even reverse, the disease.